Diabetes Care 25 , 13261330 (2002)
In some embodiments, the formulations described herein have a pH and/or practical osmolarity as described herein, and have a concentration of active pharmaceutical ingredient from about 0.0001% to about 60%, from about 0.001% to about 40%, from about 0.01% to about 20%, from about 0.01% to about 10%, from about 0.01% to about 7.5%, from about 0.01% to about 6%, from about 0.01 to about 5%, from about 0.1 to about 10%, or from about 0.1 to about 6% of the active ingredient by weight of the formulation
Once prepared, aliquot the solution to avoid product inactivation caused by repeated freeze-thaw cycles
By promoting angiogenesis and supporting the regulation of key growth factors, BPC-157 helps accelerate tissue repair, reduce inflammation, and assist in healing across muscles, tendons, joints, and the digestive system
Both peptides are popular research chemicals with distinct functions
Dose-response for glucagonostatic effect of amylin in rats